银屑病与抗PD-1及抗PD-L1免疫疗法：三例病例、文献综述及拟议的管理算法 - Suppr | 超能文献

Psoriasis and Anti-PD-1 and Anti-PD-L1 Immunotherapy: Three Cases, a Review of the Literature, and a Proposed Management Algorithm.

作者信息

Sánchez-Martínez E, Sáez-Belló M, Ochenduszko S, Mateu-Puchades A

机构信息

Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España.

Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España.

出版信息

Actas Dermosifiliogr. 2022 Apr;113(4):427-431. doi: 10.1016/j.ad.2020.05.017. Epub 2021 Sep 10.

DOI:10.1016/j.ad.2020.05.017

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Psoriasis and Anti-PD-1 and Anti-PD-L1 Immunotherapy: Three Cases, a Review of the Literature, and a Proposed Management Algorithm.银屑病与抗PD-1及抗PD-L1免疫疗法：三例病例、文献综述及拟议的管理算法

Actas Dermosifiliogr. 2022 Apr;113(4):427-431. doi: 10.1016/j.ad.2020.05.017. Epub 2021 Sep 10.

2

Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study.抗PD-1或抗PD-L1免疫疗法诱导的血液学免疫相关不良事件：一项描述性观察研究。

Lancet Haematol. 2019 Jan;6(1):e48-e57. doi: 10.1016/S2352-3026(18)30175-3. Epub 2018 Dec 4.

3

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.使用免疫检查点抑制剂的癌症免疫疗法诱导的肝损伤的特征。

J Hepatol. 2018 Jun;68(6):1181-1190. doi: 10.1016/j.jhep.2018.01.033. Epub 2018 Feb 8.

4

Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.抗 PD-1/PD-L1 阻断免疫疗法治疗乙型肝炎病毒感染相关的晚期肝细胞癌：文献综述。

Front Immunol. 2020 May 28;11:1037. doi: 10.3389/fimmu.2020.01037. eCollection 2020.

5

Case Report: Vaccination by Autologous CD16 Dendritic Cells and Anti-PD-L 1 Antibody Synergized With Radiotherapy To Boost T Cells-Mediated Antitumor Efficacy In A Psoriatic Patient With Cutaneous Squamous Cell Carcinoma.病例报告：自体 CD16 树突状细胞疫苗接种联合抗 PD-L1 抗体与放射治疗协同作用，增强 T 细胞介导的抗肿瘤疗效，用于治疗患有皮肤鳞状细胞癌的银屑病患者。

Front Immunol. 2021 Dec 23;12:752563. doi: 10.3389/fimmu.2021.752563. eCollection 2021.

6

Bullous dermatoses secondary to anti-PD-L1 agents: a case report and review of the literature.抗程序性死亡受体配体1（PD-L1）药物继发的大疱性皮肤病：一例病例报告及文献复习

Dermatol Online J. 2019 Oct 15;25(10):13030/qt7qg9675d.

7

The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.检查点抑制对头颈部鳞状细胞癌的影响：系统评价。

Oral Oncol. 2019 Mar;90:67-73. doi: 10.1016/j.oraloncology.2019.01.018. Epub 2019 Feb 5.

8

Clinical management of Anti-TNF-alpha-induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review.炎症性肠病患者抗 TNF-α 诱导的银屑病或银屑病样病变的临床处理：系统评价。

Int J Dermatol. 2018 Dec;57(12):1521-1532. doi: 10.1111/ijd.14072. Epub 2018 Jul 20.

9

Clinical and molecular characteristics associated with survival among cancer patients receiving first-line anti-PD-1/PD-L1-based therapies.接受基于一线抗PD-1/PD-L1疗法的癌症患者生存相关的临床和分子特征。

Biomarkers. 2020 Sep;25(6):441-448. doi: 10.1080/1354750X.2020.1794042. Epub 2020 Aug 3.

10

The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy.PD-1 和 PD-L1 检查点信号抑制在乳腺癌免疫治疗中的最新进展。

Eur J Pharmacol. 2021 Mar 15;895:173867. doi: 10.1016/j.ejphar.2021.173867. Epub 2021 Jan 15.

引用本文的文献

1

CRISPR/Cas9-Mediated Knockout and Overexpression Studies Unveil the Role of PD-L1 in Immune Modulation in a Psoriasis-like Mouse Model.CRISPR/Cas9介导的基因敲除和过表达研究揭示了程序性死亡配体1（PD-L1）在银屑病样小鼠模型免疫调节中的作用。

Inflammation. 2025 Apr 3. doi: 10.1007/s10753-025-02281-w.

2

Cytokine release syndrome induced by anti-programmed death-1 treatment in a psoriasis patient: A dark side of immune checkpoint inhibitors.一名银屑病患者接受抗程序性死亡-1治疗引发的细胞因子释放综合征：免疫检查点抑制剂的阴暗面

World J Clin Cases. 2024 Dec 16;12(35):6782-6790. doi: 10.12998/wjcc.v12.i35.6782.